IL76289A - Tumor therapeutic agent and a process for its preparation - Google Patents

Tumor therapeutic agent and a process for its preparation

Info

Publication number
IL76289A
IL76289A IL76289A IL7628985A IL76289A IL 76289 A IL76289 A IL 76289A IL 76289 A IL76289 A IL 76289A IL 7628985 A IL7628985 A IL 7628985A IL 76289 A IL76289 A IL 76289A
Authority
IL
Israel
Prior art keywords
therapeutic agent
preparation
tumor therapeutic
monoclonal antibodies
antigens
Prior art date
Application number
IL76289A
Other languages
English (en)
Other versions
IL76289A0 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL76289A0 publication Critical patent/IL76289A0/xx
Publication of IL76289A publication Critical patent/IL76289A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Window Of Vehicle (AREA)
  • Saccharide Compounds (AREA)
IL76289A 1984-09-06 1985-09-04 Tumor therapeutic agent and a process for its preparation IL76289A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843432714 DE3432714A1 (de) 1984-09-06 1984-09-06 Tumortherapeutikum und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
IL76289A0 IL76289A0 (en) 1986-01-31
IL76289A true IL76289A (en) 1992-01-15

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76289A IL76289A (en) 1984-09-06 1985-09-04 Tumor therapeutic agent and a process for its preparation

Country Status (13)

Country Link
EP (1) EP0173951B1 (de)
JP (1) JPS6168427A (de)
AT (1) ATE64531T1 (de)
CA (1) CA1277600C (de)
DE (2) DE3432714A1 (de)
DK (1) DK172253B1 (de)
ES (1) ES8704082A1 (de)
FI (1) FI88360C (de)
GR (1) GR852149B (de)
IE (1) IE58638B1 (de)
IL (1) IL76289A (de)
PT (1) PT81093B (de)
ZA (1) ZA856807B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AT398900B (de) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vakzine für eine immuntherapie
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
JP4204642B2 (ja) * 1992-11-05 2009-01-07 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ 前立腺に特異的な膜抗原
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
DE69635801T2 (de) 1995-02-24 2006-11-02 Sloan-Kettering Institute For Cancer Research Prostataspezifisches membranes antigen und seine anwendungen
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
WO2003034903A2 (en) 2001-10-23 2003-05-01 Psma Development Company, L.L.C. Psma antibodies and protein multimers
CN1315536C (zh) * 2002-09-13 2007-05-16 李进 肿瘤抗原疫苗及其制备方法和疫苗组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (de) * 1976-09-25 1978-04-06 Bayer Ag Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
IE58638B1 (en) 1993-10-20
DK402485A (da) 1986-03-07
DE3432714A1 (de) 1986-04-24
DK402485D0 (da) 1985-09-03
IE852191L (en) 1986-03-06
ES8704082A1 (es) 1987-03-16
ES546701A0 (es) 1987-03-16
CA1277600C (en) 1990-12-11
FI88360B (fi) 1993-01-29
EP0173951A3 (en) 1988-06-08
FI853389A0 (fi) 1985-09-04
EP0173951B1 (de) 1991-06-19
ZA856807B (en) 1986-04-30
GR852149B (de) 1986-01-03
IL76289A0 (en) 1986-01-31
PT81093A (de) 1985-10-01
PT81093B (pt) 1988-07-01
JPS6168427A (ja) 1986-04-08
ATE64531T1 (de) 1991-07-15
FI88360C (fi) 1993-05-10
DE3583265D1 (de) 1991-07-25
FI853389L (fi) 1986-03-07
DK172253B1 (da) 1998-02-09
EP0173951A2 (de) 1986-03-12

Similar Documents

Publication Publication Date Title
IL90990A0 (en) Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof
DE3269625D1 (en) Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use
EP0161606A3 (en) Drug, and methods of preparing and using it for treatment of tumors
HUT71193A (en) Tumor specific monoclonal antibody and cell line and pharmaceutical preparations containing them
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
IL76289A (en) Tumor therapeutic agent and a process for its preparation
DE3173342D1 (en) Agent for tumor localization and therapy with labeled antibodies and antibody fragments
ZA897858B (en) Family of high affinity,modified antibodies for cancer treatment
DE3163162D1 (en) Platinum-isocitrate complex, process for its preparation and its therapeutical application
MX9605895A (es) Anticuerpos monoclonales humanos especificos para antigeno de superficie de glioma independiente del ciclo celular.
EP0194851A3 (de) Therapie der menschlichen Tumore
ZA837857B (en) Platinum-diamine complexes,a process for the preparation thereof and a process for the preparation of a medical composition using such a complex for the treatment of cancer
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
ZA772648B (en) Tumor antigen and process for the preparation thereof
EP0268640A4 (de) Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2.
EP0042428A4 (de) Gereinigtes menschliches prostat-antigen.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
EP0328578A4 (de) Von mca 16-88 erkanntes antigen.
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
GB2048069B (en) Medicinal preparations for treating carcinomas
EP0207170A4 (de) Verfahren zur herstellung menschlicher krebsspezifischer monoklonaler antikörper.
EP0341318A4 (en) Novel platinum (ii) complex, process for preparing the same, and therapeutic agent for malignant tumor
IE873394L (en) Material for treatment of ammonia.
AR245225A1 (es) Composiciones para el tratamiento de cuero.
JPS6490158A (en) 1,2-diamino compound, manufacture and medicine for treating cardiac disease and circulatory disease

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force